BioSpace News Archive

Mirum Pharmaceuticals, Inc. announced that data from LIVMARLI® oral solution clinical studies evaluating patients with Alagille syndrome were published in Hepatology.

NanoVibronix, Inc., a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave Portable Ultrasonic Therapeutic Devices, announced that it has entered into a distribution agreement with Mio-Guard, LLC for the sale and distribution of its PainShield MD product.

Jaguar Health, Inc. announced that Ladenburg Thalmann is hosting a live virtual “Duologue Series” discussion at 1:00 p.m. EDT on June 22, 2023 with Lisa Conte, Jaguar’s founder, president and CEO.

Palisade Bio announced that J.D. Finley, Chief Executive Officer of Palisade Bio will present at the Healthcare Virtual Conference Part II, presented by Maxim Group LLC and hosted by M-Vest on Thursday, June 22, 2023 at 11:30 AM ET.

Nanotein Technologies, a trailblazing leader in innovative cell therapy reagents, recently launched their latest addition to the NanoSpark™ product line: NanoSpark™ GROW-NK Soluble Activator.

Labcorp is pleased to share that its executive vice president and chief marketing officer, Amy Summy, has been awarded the inaugural Forrester Customer Obsession Leadership Award, recognizing senior executives who put customers at the center of everything they do to accelerate business growth, retain customers and enable greater employee engagement.

CNS Pharmaceuticals, Inc. announced that John Climaco, Chief Executive Officer of CNS Pharmaceuticals will present at the Healthcare Virtual Conference Part II, presented by Maxim Group LLC and hosted by M-Vest on Wednesday, June 21, 2023 at 2:30 PM ET.

Cala today announced the commercial launch of its next generation system: the Cala kIQ™ System, the first and only FDA-cleared wearable device that delivers effective therapy for action hand tremor relief in people with essential tremor and Parkinson’s disease.

GlobeStar Therapeutics Corporation and Advanced Innovative Partners announced that they have entered into a memorandum of understanding collaboration agreement to design and implement clinical trials for Project Amethyst™, a compound intended to treat neurodegeneration from Multiple Sclerosis.

Swiss American CDMO and BioNTX have partnered to host the inaugural Biotechnology and Healthcare Industry Alliance of North Texas launch meeting that will champion a next generation, industry-led, workforce partnership.